EBR SYSTEMS, INC. (ARBN 654 147 127) 4600 Patrick Henry Drive, Santa Clara CA 95054 USA T: +1 408 720 1906 W: https://ebrsystemsinc.com/ ASX ANNOUNCEMENT 15 September 2026 FDA initiates inspection of new manufacturing facility Santa Clara, California; 15 September 2026: EBR...
FDA Initiates Inspection of New Manufacturing Facility
Filed with ASX · · 2 pages · English
Summary by 6ix AI
EBR Systems, Inc. has announced that the FDA has initiated a pre-approval inspection of its new manufacturing facility in Santa Clara, California, marking a significant regulatory milestone for the company. The company anticipates FDA approval of the facility by the end of the year, which is crucial for its operations in developing wireless cardiac pacing devices.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from EBR Systems
- Investor Roadshow
- Update on FDA Review of Cybersecurity Incident
- New Manufacturing Facility Achieves ISO Certification
- Cleansing Notice
- Application for quotation of securities - EBR
Later from EBR Systems
- EBR FDA Plan for Addressing Echo-induced Pacing Risks
- CMS Finalises Increased Inpatient Reimbursement for WiSE
- Substantial Holding Notification
- Upcoming Australian Investor Conferences
- Completion of FDA Inspection of New Manufacturing Facility
Follow EBR Systems into a list and get an email when it puts out news.
Follow EBR Systems